Cargando…

Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch(TM) Microneedle Delivery System

Measles (Me) and rubella (Ru) viral diseases are targeted for elimination by ensuring a high level of vaccination coverage worldwide. Less costly, more convenient MeRu vaccine delivery systems should improve global vaccine coverage, especially in low – and middle – income countries (LMICs). In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Ying, Gupta, Vineet, Bird, Christopher, Pullagurla, Swathi R., Fahey, Paul, Forster, Angus, Volkin, David B., Joshi, Sangeeta B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475600/ https://www.ncbi.nlm.nih.gov/pubmed/33957843 http://dx.doi.org/10.1080/21645515.2021.1887692

Ejemplares similares

Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array
por: Wan, Ying, et al.
Publicado: (2018)

Microneedles and Nanopatches-Based Delivery Devices in Dentistry
por: Batra, Panchali, et al.
Publicado: (2020)

Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery
por: Kumar, Prashant, et al.
Publicado: (2021)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination
por: Prausnitz, Mark R, et al.
Publicado: (2020)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
por: Kumar, Prashant, et al.
Publicado: (2022)

Colloidal Synthesis of Nanopatch Antennas for Applications in Plasmonics and Nanophotonics
por: Hoang, Thang B., et al.
Publicado: (2016)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Measles & rubella outbreaks in Maharashtra State, India
por: Vaidya, Sunil R., et al.
Publicado: (2016)

Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]
por: Adigweme, Ikechukwu, et al.
Publicado: (2022)

Purulent Bronchitis Complicating Measles and Rubella
Publicado: (1919)

Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018
por: Brown, Kevin E., et al.
Publicado: (2019)

Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
por: Saffar, Hana, et al.
Publicado: (2021)

Plasmonic nanopatch array for optical integrated circuit applications
por: Qu, Shi-Wei, et al.
Publicado: (2013)

Optically pumped subwavelength-scale metallodielectric nanopatch resonators
por: Kwon, Kyungmok, et al.
Publicado: (2016)

Effect of the Hematocrit and Storage Temperature of Dried Blood Samples in the Serological Study of Mumps, Measles and Rubella
por: Rodríguez-Mateos, Mariano, et al.
Publicado: (2023)

Rubella and Its Relations to Scarlet Fever and Measles
Publicado: (1908)

2017 Measles-Rubella Vaccination Campaign in India
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2018)

Expansion of the measles and rubella laboratory network, India
por: Sharma, Deepa, et al.
Publicado: (2022)

Differential Diagnosis of Scarlet Fever, Measles and Rubella
Publicado: (1919)

1148. Long-term Persistence of Measles and Rubella Virus Neutralizing Antibody Levels among Adults with Three Doses of Measles-Mumps-Rubella Vaccine
por: Alonge, Oluwakemi, et al.
Publicado: (2023)

Modified measles versus rubella versus atypical measles: One and same thing
por: Gupta, Surender Nikhil, et al.
Publicado: (2015)

The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries
por: Vynnycky, Emilia, et al.
Publicado: (2018)

Mass Measles Rubella Immunization Campaign: Bhutan Experience
por: Giri, Bhakta R, et al.
Publicado: (2011)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
por: Heijstek, MW, et al.
Publicado: (2008)

Characterizing the dynamics of rubella relative to measles: the role of stochasticity
por: Rozhnova, Ganna, et al.
Publicado: (2013)

Strengthening routine immunization through measles-rubella elimination
por: Biellik, Robin J., et al.
Publicado: (2018)

Measles-Rubella vaccination campaign: A trust deficit?
por: Sreedevi, A
Publicado: (2018)

Is it time to reconsider measles, mumps, and rubella immunisation strategies?
por: Boccalini, Sara, et al.
Publicado: (2021)

Measles-Mumps-Rubella Vaccine and COVID-19 Relationship
por: Özdemir, Öner
Publicado: (2020)

Towards elimination of measles and rubella in Italy: Progress and challenges
por: Adamo, Giovanna, et al.
Publicado: (2019)

Cost of conducting Measles-Rubella vaccination campaign in India
por: Chatterjee, Susmita, et al.
Publicado: (2021)

Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018(TM) Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
por: Bajoria, Sakshi, et al.
Publicado: (2023)

Immunogenicity of measles-rubella vaccine administered under India’s Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study
por: Verma, Santosh Kumar, et al.
Publicado: (2023)

Biologically Targeted Photo‐Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion
por: Mi, Yu, et al.
Publicado: (2019)

Mode-Matching Enhancement of Second-Harmonic Generation with Plasmonic Nanopatch Antennas
por: Noor, Ahsan, et al.
Publicado: (2020)

2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8d58jnabbc8734henssu0lr4kf